ING proteins have an essential role in the control of a variety of cellular functions whose deregulation is associated with tumor formation and dissemination, such as proliferation, apoptosis, senescence or invasion. Accordingly, loss of function of ING proteins is a frequent event in many types of human tumors. In this report, we have studied the function of ING4, a member of the ING family of tumor suppressors, in the context of normal, non-transformed primary fibroblasts. We show that ING4 negatively regulates cell proliferation in this cell type. The antiproliferative action of ING4 requires its ability to recognize chromatin marks, it is p53-dependent at least in part, and it is lost in an ING4 cancer-associated mutant. Gene expression analysis shows that ING4 regulates the expression and release of soluble factors of the chemokine family. The secretory phenotype regulated by ING4 in primary fibroblasts displays a selective paracrine effect on proliferation, fostering the division of tumor cells, while inhibiting division in primary fibroblasts. Consistently, ING4-expressing fibroblasts promoted tumor growth in vivo in co-injection tumorigenesis assays. Collectively, our results show that ING4 not only can regulate the proliferation of primary non-transformed human fibroblasts, but also orchestrates a secretory phenotype in these cells that promotes tumor cell proliferation in vitro and in vivo. These findings support a critical role for ING4 expression in normal cells in the non-cell-autonomous regulation of tumor growth.
INTRODUCTION
ING proteins are putative tumor suppressors that control key cellular functions frequently altered during tumor initiation or progression, including cell division, apoptosis or motility. [1] [2] [3] [4] ING proteins act primarily as chromatin-mediated regulators of gene expression, in association with transcription factors like p53 or NF-kB. ING proteins fulfil this function through the specific reading of the active histone mark H3K4me3, and their participation in complexes with histone acetylation or deacetylation activity. 2, 5, 6 The ING family includes several sequence-related proteins, encoded in five loci in human and mice, many of which produce several alternative isoforms. Among the ING family, ING4 displays a series of distinctive features consistent with its participation in both tumor initiation and progression. Like other ING proteins, ING4 can control cell proliferation and apoptosis. [7] [8] [9] In addition to these common functions, ING4 can also regulate cell motility, invasion and angiogenesis, supporting an important role for this ING protein in suppression of tumor cell invasion and metastatic spread. [10] [11] [12] [13] It is assumed that ING4 regulates these processes mainly via the transcriptional control of specific target genes, although a direct role of the ING4 in the cytoplasm has also been described. 11 Consistent with a role as tumor suppressor, ING4 function is impaired in multiple human tumors, by diverse mechanisms. For instance, the ING4 locus is deleted in 20% of breast tumors, and reduced ING4 expression can be found in glioblastoma, lung carcinoma or melanoma, among other tumor types. 8, 10, 12, 14 A correlation between ING4 alterations and high malignancy grade and increased tumor angiogenesis has been reported in several studies. 10, 12 Besides these cancer-related functions, ING4 also has a key role in control of innate immunity in vivo, presumably in connection with the NF-kB pathway, as indicated by defective inflammatory response in Ing4-mutant mice. 15 Our current knowledge of ING4 function in cancer is based mainly on studies with immortalized or tumor cells. In this report, we wished to understand the role of ING4 in the context of normal primary cells, in order to gain insights in the physiological role of this protein. To this end, we used for our studies earlypassage human primary embryonic fibroblasts. These cells are genetically normal, and retain fully functional tumor-suppressive pathways. Accordingly, they have been widely used as a cellular model to study processes relevant for tumor suppression, including cellular senescence. 16 Our results show that ING4 can inhibit the proliferation of human fibroblasts, and this effect requires, at least partially, the recognition of histone marks by ING4 and the presence of functional p53. More importantly, we show that ING4 can regulate a secretory phenotype in primary fibroblasts, which differentially regulates proliferation of primary or transformed cells in vitro, and promotes tumor growth in vivo. These results unveil a novel role for ING4 in paracrine crosstalk in tumors and suggest that ING4 expression in non-transformed cells is a key determinant in non-cell-autonomous regulation of tumorigenesis. To study the role of ING4 in non-transformed, primary cells, we  expressed ectopically the human ING4 protein in early-passage  IMR-90 human primary fibroblasts. These cells retain normal  tumor-suppressive pathways and have been extensively  characterized as a cellular model in studies of cellular responses  relevant for tumorigenesis. As controls for these studies, we used  two mutant versions of ING4, previously characterized: ING4 N214D , henceforth N214D, a cancer-associated mutant with impaired stability and function 13 and ING4 D213A , henceforth D213A, a mutation in the PHD domain that abolishes histone mark recognition. 9 The expression of all the ING4 constructs was confirmed by western blot and quantitative PCR, after retroviral transduction and selection ( Figure 1a, Supplementary Figures S1a  and b) . To determine the impact on cell division of the enforced expression of the different ING4 versions, we measured their rate of BrdU incorporation and the cummmulative growth over a period of 8 days (Figures 1b and c) . Both assays showed that wild-type ING4 provoked a significant reduction in proliferation rates in IMR-90 cells, but this effect was significantly reduced when either ING4 mutant was used.
RESULTS

ING4 inhibits proliferation of primary fibroblasts
Link to senescence and DNA damage response Having shown an antiproliferative effect of ING4 in primary fibroblasts, we wished to elucidate the mechanism for this phenotype. Cellular senescence is an antiproliferative response, which opposes tumor formation by inhibiting the division of cells with potentially oncogenic alterations. 17 It has been reported that two ING proteins (ING1 and ING2) are regulators of cellular senescence, and their ectopic expression suffices to trigger a senescent phenotype in primary fibroblasts. [18] [19] [20] [21] With this background, we tested if ING4 could have a similar pro-senescent action that could account for the antiproliferative effect observed. To this end, we investigated if a senescent phenotype was induced in IMR-90 fibroblasts expressing wild-type or mutant ING4. The activated version of the Ha-Ras oncogene (RasV12) was used as a positive control for induction of senescence. 22 The following senescence markers were used: senescence-associated beta galactosidase staining, senescence-associated heterochromatin foci and flattened morphology. No significant induction of senescence markers was observed in cells expressing wild-type or mutant versions of ING4, in conditions where RasV12 caused a clear induction of the senescent phenotype (Figures 2a-c Figure S1c and d) , ING4 is not a potent inductor of senescence in human primary fibroblast. We also investigated if the arrest triggered by ING4 expression could be mediated by DNA damage. It has been suggested that other ING proteins have a role in the response to genotoxic stress in connection with the repair machinery or through changes in global chromatin structure and accessibility. 23, 24 To test this hypothesis, we analyzed by immunofluorescence the presence of g-H2AX, a marker of DNA damage foci. We detected a small but statistically significant increase in g-H2AX-positive cells with wild-type ING4, which was absent in cells with ING4 mutants defective in cell-cycle arrest (Figure 2d ).
Connection to tumor suppressor pathways To investigate further the mechanism of the antiproliferative effect of ING4, we sought to determine the implication of the p53 and retinoblastoma (Rb) pathways. It has been reported that ING4 is functionally linked to p53. 7 In addition, both tumor-suppressive pathways have critical roles in control of cell proliferation and other essential responses in primary cells. 25 For this purpose, we transduced IMR-90 cells with short-hairpin RNA (shRNA) vectors against p53 or Rb to stably inactivate these pathways, followed by ectopic expression of ING4 and measured the growth rate of these cells ( Figure 3a) . As a control, RasV12 was also used in these assays. 26 Inactivation of p53 by itself caused a small increase in BrdU incorporation (42 ± 11 vs 32 ± 6%), as expected. 
ING4 regulates the expression of chemokine-soluble factors
The best-characterized molecular function of ING4 is as a regulator of gene expression, by the recognition and establishment of chromatin marks in cooperation with transcription factors. To identify genes that mediate the phenotype provoked by ectopic ING4 in primary fibroblasts, we analyzed the expression profiles of these cells, using expression arrays. To this end, early-passage IMR-90 fibroblasts were infected with vectors encoding wild-type ING4, the N214D mutant, or empty vector as a control. Total RNA was prepared at 6 days post selection, the same time as for functional assays, and used to hybridize human whole-genome arrays. A subset of 87 genes showed differential expression in IMR-90 fibroblasts with wild-type ING4, relative to vector-infected fibroblasts (see Materials and Methods) of which 81 were upregulated in ING4-expressing cells and 6 genes were downregulated. Next, we compared the expression of these genes in IMR-90 fibroblasts expressing the loss-of-function N214D mutant. We observed that 50 out of the 87 genes in this group (nearly twothirds) did not show differential expression with the ING4 mutant, relative to vector-infected fibroblasts, supporting the specificity of the ING4 signature ( Figure 4a ). Functional category classification of these results revealed a statistically significant enrichment in genes involved in proliferation, cytokine activity and inflammation ( Figure 4b ). Prompted by these results, we decided to focus our study in genes involved in cytokine and chemokine signaling regulated by ING4 in primary fibroblasts. The differential expression of a selection of chemokines identified in the array (and interleukin (IL)-6, which has been previously associated with ING4) was validated by quantitative PCR with cells expressing wild-type and the N214D or D213A mutants ( Figure 4c and Supplementary Figure S3 ). Using chromatin immunoprecipitation, we showed that ING4 can bind directly to the promoter of CXCL1, one of the soluble factors regulated in ING4-expressing cells (Figure 4d ), suggesting that the changes in expression we observed reflect direct transcriptional effects of ING4, as previously described.
9,27
To obtain further confirmation of the effect of ING4 in production and release of these factors, we analyzed the presence of soluble factors in the conditioned medium of fibroblasts expressing ING4, using a commercial chemokine antibody array (see Material and Methods). Two independent experiments consistently showed an overall increase in soluble chemokines in the medium conditioned by ING4-expressing fibroblasts, relative to vector controls 
Effects of ING4-conditioned medium on cell proliferation
To characterize the non-cell-autonomous role of ING4 expression in primary fibroblasts, we carried out experiments to assay the paracrine effect of ING4-conditioned medium in cell proliferation of primary and transformed cells. Conditioned medium obtained from IMR-90 primary fibroblasts expressing wild-type or mutant ING4 was added to different cell types to test its impact on cell proliferation. We observed that the addition of ING4-conditioned medium to non-infected IMR-90 primary fibroblasts ( Figure 5a ) provoked a clear reduction in their growth rate, which was not present when mutant ING4 was used. On the contrary, the same assay using the aggressive breast cancer cell line MDA-MB-231 ( Figure 5b) showed that ING4-conditioned medium enhanced the proliferation of these tumor cells, and this effect was also lost with the N214D mutant. This differential effect on proliferation was further confirmed with growth curves and using the D213A mutant (Supplementary Figure S4a , and data not shown). IL-8 is one of the chemokines more clearly regulated by ING4. To test if the effect of the conditioned medium was mediated, at least in part, by this factor, we carried out additional proliferation assays using a blocking antibody against IL-8 ( The specific downstream mediators of the antiproliferative response to ING4 in primary fibroblasts remain to be identified. We have analyzed the cell-cycle inhibitors p16, p21 or p27, but we have not observed consistent upregulation of any of these essential cell-cycle regulators in response to ING4 (Supplementary Figure S2b) . The antiproliferative effect of ING4 in these cells may also be related to its ability to induce a weak DNA damage response, but this needs to be investigated in more detail. In addition to its cell-autonomous effect in proliferation, we show here that ING4 regulates in primary fibroblasts the synthesis of soluble factors with a selective paracrine mitogenic effect, which can promote the proliferation of tumor cells but inhibits proliferation of normal fibroblasts. More importantly, this effect can be translated to tumor growth in vivo, as supported by our findings that fibroblasts expressing ING4 can promote tumorigenesis when co-injected with breast cancer cells subcutaneoulsy or orthotopically in the mammary fat pad. The secretory phenotype that we have characterized shares features with those associated to diverse categories of non-transformed cells that are connected to tumorigenesis. First, cancer-associated fibroblasts, present in The ING4 secretory phenotype promotes tumor growth A Moreno et al the tumor microenvironment, produce cytokines, chemokines and extracellular matrix components that can cause tumor growth, angiogenesis and metastasis. 28, 29 Also, cytokines and chemokines have been associated with senescence, a tumor-suppressive mechanism, as part of the senescence-associated secretory phenotype. [30] [31] [32] [33] [34] [35] Thus, the 'ING4-fibroblast' signature partially overlaps with secretory phenotypes linked to senescent fibroblasts or to carcinoma-associated fibroblasts. Interestingly, both secretory phenotypes have overlapping functions, such as the selective promotion of tumor growth. 28, 32 In the case of the senescence-associated secretory phenotype, it has been reported that these factors can have antagonistic effects similar to the ones shown here for ING4, promoting senescence in non-transformed cells, and inducing proliferation of malignant epithelial cells in vitro and in vivo. [34] [35] [36] Our results fail to support a direct role for ING4 in senescence in vitro, in contrast to other ING proteins. [19] [20] [21] A role in senescence has been shown so far for ING1 and ING2, which form a subset of ING proteins primarily associated to transcriptional repression. In turn, ING4 is closely related to ING5 and they mainly participate in activating complexes. 5 In this regard, it should be noted that ING1 and ING4 regulate similar but not identical sets of cytokine/chemokine-related genes in primary fibroblasts (Abad et al. 19 and this report), with the ING1-specific signature being more similar to the senescence-associated secretory phenotype than the ING4 signature. These observations raise the possibility that induction of senescence is a distinct feature of the repressor INGs, not shared by all the members of the family. However, despite the negative data shown here, we cannot completely rule out a role for ING4 in senescence, and it remains possible that it might contribute to this response. Many of the soluble factors upregulated in ING4-expressing cells are known targets of NF-kB, as is the case for CXCL1, CXCL2 and IL-8. These results are consistent with a role of ING4 as a positive regulator of this pathway in our cellular model. Previous studies with overexpression or silencing of ING4 in tumor cell lines have suggested that ING4 can act as a negative regulator of some NF-kB target genes. 10, 27, 37 In contrast, data from Ing4-deficient macrophages support a differential role of ING4 on NF-kBmediated regulation. 15 Our results raise the interesting possibility that the link between ING4 and NF-kB can vary in different cell types or in primary cells versus immortalized or tumor cells. In this regard, it is worth noting that NF-kB-mediated effects are strongly context dependent. Activation of this pathway has been associated to tumorigenesis in diverse tumor types. 38 However, recent reports clearly indicate that the activation of the NF-kB pathway in primary fibroblasts is associated with an antiproliferative effect mediated by regulation of soluble factors, 31, 39, 40 many of which coincide with those controlled by ING4 in our work. In summary, our results have unveiled an important role for ING4 in the regulation of soluble factors in primary fibroblasts that can influence tumor growth and progression. Our data imply that the expression level of ING4 in non-transformed cells, and not only in tumor cells, may be relevant for tumor growth and progression.
MATERIALS AND METHODS Mutagenesis
Mutant versions of ING4 were generated with the Quick Change SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA, USA), using the complementary DNA of the human ING4 protein cloned in the retroviral vector pLPC. Specific mutations were incorporated by PCR using Pfu Turbo DNA Polymerase (Stratagene), and subsequent digestion with DpnI, and they were confirmed by sequencing.
Cell culture IMR-90 primary human diploid fibroblasts were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and used at a population doubling level lower than 30. The breast tumor cell line MDA-MB-231, containing the TGL cassette (luciferase/GFP), was provided by Roger Gomis and Joan Massagué . 41 Cells were grown in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) with 10% fetal calf serum and antibiotics, at 37 1C in 5% CO2.
Retroviral transduction
Retroviral infection was performed as described previously in Abad et al.
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The following vectors were used: pLPC, pLPC-HA-ING4, pLPC-HA-ING4D213A, pLPC-HA-ING4N214D, pLPC-RasV12, pRetroSuper, pRetroSuper-p53 and pRetroSuper-Rb (a kind gift of Daniel Peeper, NKI, Amsterdam). After infection, cells were selected with puromycin (2 mg/ml), hygromicin (75 mg/ ml) or blastycidin (10 mg/ml) for a period from 3 to 6 days.
Western blot
Preparation of total lysates and western blot analysis were carried out as described in Palmero et al. 42 The antibodies used were: anti-HA (1:500, 12CA5, Roche, Manheim, Germany); anti-ING4: (1:500, 16188-1-AP, Proteintech, Chicago, IL, USA); anti-cyclin A (1:1000, SC-751, Santa Cruz, Heidelberg, Germany); anti-p21 (1:500, C-19, Santa Cruz); anti-p27 (1:500, 554069, BD Pharmingen, San Jose, CA, USA); anti-p16 (1:200, JC8, CRUK, London, UK); anti-p53 (1:500, DO-1, Santa Cruz); anti-Rb (1:1000, 554136, BD Pharmingen); anti-actin (1:10000, AC-15, Sigma, St Louis, MO, USA) and anti-tubulin (1:10000, T9026, Sigma).
Reverse transcriptase quantitative PCR Total RNA was prepared using Tri Reagent (Sigma) from asynchronously growing cells. RNA was used for complementary DNA síntesis using M/MLV reverse transcriptase (Promega, Madison, WI, USA). One microliter of the reaction was used to perform PCR reactions. Assays were performed using Universal Probe Library probes in an ABI9700 machine (Invitrogen, Carlsbad, CA, USA), using 18S ribosomal RNA as internal reference. 
Cell culture assays
BrdU incorporation of IMR-90 cells was performed as previously described 19 by immunofluorescence with an anti-BrdU antibody (1:1000, BP40250, Megabase Research Products, Lincoln, NE, USA) except that 4-h BrdU pulses were used. g-H2AX (1:500, JBW301, Upstate, Billerica, MA, USA) was detected by immunofluorescence as described. 19 Growth curves and senescence-associated beta galactosidase activity were performed as described. 19 
Microarray gene expression profiles
Microarray experiments were performed essentially as described, 19 using Human Whole-Genome array G4112F (Agilent Technologies, Santa Clara, CA, USA). Two independent retroviral infections were performed in early pasaje IMR-90 fibroblasts with wild-type ING4 and the N214D mutant. Total RNA was labeled and competitively hybridized to arrays using as a reference a reverse-labeled sample from vector-infected cells. Expression Omnibus under the accession number of GSE42412 (submitter GM-B).
Chromatin immunoprecipitation
Chromatin immunoprecipitation assays were performed essentially as described in Gomez-Cabello et al. 43 using 293T cells transfected with HA-tagged ING4.
Conditioned media assays
To obtain the conditioned media from infected and selected IMR-90 cells, cells were grown until B90% confluence, washed with phosphate-buffered saline (PBS) and incubated in serum-free medium for 72 h. After that time, medium was collected, cleared by centrifugation and stored at À 80 1C until use. For growth assays, serum was added at a final concentration of 1%. In some experiments, an antibody against IL-8 was also added at different concentrations.
Enzyme-linked immunosorbent assay and chemokine arrays Conditioned media obtained from infected and selected IMR-90 cells were used for IL-8 enzyme-linked immunosorbent assay assays (D8000C, R&D Systems, Minneapolis, MN, USA), and to hybridize a chemokine antibody array (Human Cat #AAH-CHE-1, Ray Biotech, Norcross, GA, USA) following manufacturer instructions in both cases. The array signal was quantified by densitometry using ImageJ software (NIH, Bethesda, MD, USA) and relativized to the signal of the internal positive controls.
Tumor growth assays IMR-90 infected with wild-type ING4 or empty vector, used at day 6 after selection, and MDA-MB-231-TGL cells growing at subconfluence were trypsinized and mixed in a 3:1 ratio (6 Â 10 5 and 2 Â 10 5 per injection, respectively). Cells were resuspended in a final volume of 100 ml de PBS per injection, and were inoculated subcutaneously in the flanks or in the mammary fat pads of female 6-to 8-week-old nu/nu mice. For detection of bioluminiscence, 200 ml of a solution of D-luciferin (15 mg/ml in PBS) was injected intraperitoneally in anesthetized mice. Images were obtained at different points, starting B5 min after the injection, with a Xenogen IVIS Lumina II apparatus and analyzed with the Living Image Acquisition and Analysis Software (Xenogen Corporation, Alameda, CA, USA). Bioluminescence intensity was measured at the peak of emission as the total photon flux (photons/second/cm 2 ) for each region of interest. Measurements were repeated every 7 days and relativized to the data obtained in the first measurement for each ROI. Tumor volume was measured at the same time points with a caliper, using the formula V ¼ A Â B 2 /2 (mm 3 ), where A is the largest diameter and B is the perpendicular diameter. Five weeks after cell injection, mice were killed and the tumors were removed, weighed and processed for immunohistochemistry.
Immunohistochemical analysis
Tumors were fixed in formalin and processed for paraffin embedding. Fivemicrometer sections were deparaffinized and rehydrated, treated 10 min with 3% H 2 O 2 in methanol to inhibit the endogenous peroxidase activity, followed by washes with 0.1% PBS-Triton. The slides were then blocked with 1% bovine serum albumin in 0.1% PBS-Triton for 30 min, washed again with 0.1% PBS-Triton and incubated with anti-GFP antibody overnight at 4 1C (1:100, A6455, Invitrogen, Carlsbad, CA, USA). After washings with 0.1% PBS-Triton, samples were incubated 30 min with an anti-rabbit secondary antibody HRP-labeled (K4002, DAKO, Glostrup, Germany) at room temperature. After washing, color was developed with diaminobenzidine (DAKO) and sections were counterstained with hematoxylin for 5 s. Finally, samples were dehydrated, mounted in DPX (Sigma) and analyzed in a Nikon90i microscope (Nikon, Tokyo, Japan) at Â 4 and Â 10 magnification.
Statistics
Statistical significance was estimated using the Student's t-test.
